Global stability of a HIV-1 CCR5 gene therapy with suicide gene
In AIDS treatment, gene therapy targeting only CCR5 co-receptors cannot suppress HIV-1 (this is consistent with current data). When we construct a mathematical model, it is assumed that the same gene therapy combined with the expressed suicide gene only in HIV-1 infection can significantly improve t...
Saved in:
| Main Authors: | Junmei Liu, Yonggang Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Systems Science & Control Engineering |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21642583.2023.2291407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global stability of an HIV-1 model with distributed intracellular delays and a combination therapy
by: Shengqiang Liu, et al.
Published: (2010-05-01) -
CCR5 gene editing and HIV immunotherapy: current understandings, challenges, and future directions
by: Jia-Wen Wang, et al.
Published: (2025-06-01) -
Promoter Methylation of HIV Coreceptor-Related Genes CCR5 and CXCR4: Original Research
by: Anna Esman, et al.
Published: (2025-03-01) -
Advancement in Gene therapy: Current and Future of Gene Therapy
by: Shafee Ur Rehman
Published: (2025-03-01) -
Allelic variants of human genes affecting HIV intracellular life cycle and regulating immune response to HIV infection
by: R. M. Khaitov, et al.
Published: (2019-05-01)